IDXX Stock Summary and Trading Ideas (Idexx Laboratories | NASDAQ:IDXX)

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Idexx Laboratories trades on the NASDAQ stock market under the symbol IDXX.

As of June 4, 2026, IDXX stock price climbed to $564.74 with 609,749 million shares trading.

IDXX has a beta of 1.10, meaning it tends to be more sensitive to market movements. IDXX has a correlation of 0.14 to the broad based SPY ETF.

IDXX has a market cap of $44.55 billion. This is considered a Large Cap stock.

Last quarter Idexx Laboratories reported $1 billion in Revenue and $3.47 earnings per share. This beat revenue expectation by $30 million and exceeded earnings estimates by $.06.

In the last 3 years, IDXX traded as high as $769.98 and as low as $356.14.

The top ETF exchange traded funds that IDXX belongs to (by Net Assets): VTI, VOO, VO, QQQ, IVV.

IDXX has underperformed the market in the last year with a price return of +7.4% while the SPY ETF gained +28.2%. IDXX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.1% and +2.0%, respectively, while the SPY returned +11.5% and +2.1%, respectively.

IDXX support price is $549.09 and resistance is $572.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IDXX shares will trade within this expected range on the day.